J. Spiegel Robert's Insider Trades & SAST Disclosures
J. Spiegel Robert's most recent trade in Geron Corp. was a trade of 2,206 Common Stock done . Disclosure was reported to the exchange on Dec. 31, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern J. Spiegel Robert.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Geron Corp. | Robert J. Spiegel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2024 | 2,206 | 172,391 (0%) | 0% | 0 | Common Stock | |
| RenovoRx Inc | Robert J. Spiegel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2024 | 25,099 | 25,099 | - | - | Stock Options (right to buy) | |
| Geron Corp. | Robert J. Spiegel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2024 | 1,767 | 170,185 (0%) | 0% | 0 | Common Stock | |
| Geron Corp. | Robert J. Spiegel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2024 | 180,000 | 180,000 | - | - | Stock Option (right to buy) | |
| Geron Corp. | Robert J. Spiegel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2024 | 2,462 | 166,502 (0%) | 0% | 0 | Common Stock | |
| Geron Corp. | Robert J. Spiegel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2024 | 1,916 | 168,418 (0%) | 0% | 0 | Common Stock | |
| RenovoRx Inc | J. Robert Spiegel | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 26 Jan 2024 | 40,983 | 40,983 | - | - | Warrants | |
| RenovoRx Inc | Robert Spiegel J. | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 26 Jan 2024 | 40,983 | 40,983 | - | - | Common Stock | |
| Geron Corp. | J. Spiegel Robert | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Dec 2023 | 3,406 | 164,040 (0%) | 0% | 0 | Common Stock | |
| Cyclacel Pharmaceuticals Inc | Robert J. Spiegel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2023 | 42,438 | 42,438 | - | - | Stock Option (right to buy) | |
| Cyclacel Pharmaceuticals Inc | Robert J. Spiegel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2023 | 21,219 | 39,415 (0%) | 0% | 0 | Common Stock | |
| Geron Corp. | Robert J. Spiegel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2023 | 125,000 | 125,000 | - | - | Stock Option (right to buy) | |
| Geron Corp. | Robert J. Spiegel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2023 | 3,312 | 155,005 (0%) | 0% | 0 | Common Stock | |
| Geron Corp. | Robert J. Spiegel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Dec 2022 | 2,970 | 151,693 (0%) | 0% | 0 | Common Stock | |
| Geron Corp. | Robert J. Spiegel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2022 | 3,071 | 148,723 (0%) | 0% | 0 | Common Stock | |
| Cyclacel Pharmaceuticals Inc | Robert J. Spiegel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2022 | 31,645 | 31,645 | - | - | Stock Option (right to buy) | |
| Cyclacel Pharmaceuticals Inc | Robert J. Spiegel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2022 | 15,822 | 18,196 (0%) | 0% | 0 | Common Stock | |
| Geron Corp. | Robert J. Spiegel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2022 | 5,284 | 141,015 (0%) | 0% | 0 | Common Stock | |
| Geron Corp. | Robert J. Spiegel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2021 | 5,097 | 124,594 (0%) | 0% | 0 | Common Stock | |
| Cyclacel Pharmaceuticals Inc | Robert J. Spiegel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2021 | 4,748 | 4,748 | - | - | Stock Option (right to buy) | |
| Cyclacel Pharmaceuticals Inc | Robert J. Spiegel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2021 | 2,374 | 2,374 (0%) | 0% | 0 | Common Stock | |
| Geron Corp. | Robert J. Spiegel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2021 | 83,000 | 83,000 | - | - | Stock Option (right to buy) | |
| Geron Corp. | Robert J. Spiegel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2021 | 4,549 | 119,497 (0%) | 0% | 0 | Common Stock | |
| Geron Corp. | Robert J. Spiegel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2020 | 4,130 | 110,428 (0%) | 0% | 0 | Common Stock | |
| Geron Corp. | Robert J. Spiegel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2020 | 3,297 | 106,298 (0%) | 0% | 0 | Common Stock | |
| Cyclacel Pharmaceuticals Inc | Robert J. Spiegel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2020 | 5,200 | 5,200 | - | - | Stock Option (right to buy) | |
| Geron Corp. | Robert J. Spiegel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2020 | 83,000 | 83,000 | - | - | Stock Option (right to buy) | |
| Geron Corp. | Robert J. Spiegel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2020 | 6,039 | 103,001 (0%) | 0% | 0 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges